Propionyl-L-carnitine Propionyl-L-carnitine is not approved by the US FDA for use as a drug to prevent or treat any condition
[DOI] [PubMed] [Google Scholar] Tang Z-H, Peng J, Ren Z, Yang J, Li T-T, Li T-H, Wang Z, Wei D-H, Liu L-S, Zheng X-L, Jiang Z-S, 2017
L-carnitine treatment attenuates renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction
*Correspondence: Yuya Nakamoto [email protected] This article was submitted to Veterinary Neurology and Neurosurgery, a section of the journal Frontiers in Veterinary Science Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
10.1152/ajprenal.00590.2007 245 YangQ.GaoL.HuX.WangJ.ZhangY.DongY.et al (2021)
It enrolled 17,604 adults aged 45 or older with a body mass index (BMI) of 27 kg/m2 or greater and preexisting CVD (prior MI, prior stroke or peripheral artery disease) without diabetes